Cullinan Therapeutics OverviewCullinan Therapeutics Net Income
Profitability analysis for CGEM.
Quarterly Net Income
-$49.66M
↓ 2.39% YoY
As of Mar 2026
Annual Net Income (TTM)
-$221.04M
↓ 23.67% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...